Research Article
Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma
Table 1
Demographic and clinical statistics.
| | | Range |
| Median age (years) | 59 | (42–70) | Median height (meters) | 1.72 | (1.6–1.8) |
| | | Percentage |
| Gender | Male () | 50% | Female () | 50% | Body mass index (BMI) | BMI < 30 () | 63% | BMI 30–35 () | 22% | BMI 35–40 () | 9% | BMI 40–45 () | 3% | BMI > 45 () | 3% | Surgery | Wide local excision () | 92% | Amputation () | 8% | Surgical margins | Negative () () | 88% | Positive () () | 12% |
| | | Range |
| Median follow-up (years) | 4.1 | (1.7–5.6) | Median tumor size (cm) | 9.0 | (5.0–15.0) | Median time to death (months) | 69 | (40–89) |
| | | Percentage |
| Tumor depth (relative to investing fascia) | Superficial () | 20% | Deep () | 80% | Tumor grade | Low () | 18% | Intermediate () | 11% | High () | 71% | Histologic sarcoma type | Fibrosarcoma () | 4% | Leiomyosarcoma () | 12% | Liposarcoma () | 22% | Malignant peripheral nerve sheath tumor () | 2% | Undifferentiated pleiomorphic sarcoma () | 42% | Synovial sarcoma () | 5% | Vascular sarcoma () | 4% | Rhabdomyosarcoma () | 1% | Others () | 9% | AJCC stage at presentation | I () | 25% | II () | 20% | III () | 24% | IV () | 31% | Preoperative radiation | Yes () | 23% | No () | 77% | Postoperative radiation | Yes () | 61% | No () | 39% | Chemotherapy | Yes () | 21% | No () | 79% | Survival status at last follow-up | Alive () | 69% | Died of disease () | 17% | Died of other causes () | 7% | Uncertain cause of death () | 4% |
|
|